title: Synchronous renal cell carcinoma and gynecologic malignancies.
abstract: BACKGROUND
  Synchronicity of renal cell carcinoma and gynecologic malignancies is a rare condition and standardized treatment does not exist.
  
  
  METHODS
  Three cases of synchronous renal cell carcinoma and gynecologic malignancies are described. All three cases underwent optimal cytoreductive surgery for the gynecologic malignancy and a radical nephrectomy for the renal cell carcinoma. Adjuvant treatment, after surgery, was individualized in each case. Estrogen and progesterone receptors were positive in all the gynecologic tumors but negative in the renal cell tumors.
  
  
  CONCLUSIONS
  This is apparently the largest report of synchronous renal cell carcinoma and gynecologic malignancies. Despite this rare condition, surgery should still be considered as primary treatment for these patients.
authors.affiliation: Department of Obstetrics and Gynecology, University of Vermont/Fletcher Allen Health Care, Burlington 05401, USA. cheung.wong@vtmednet.org
authors.forename: Cheung
authors.initials: C
authors.lastname: Wong
authors.forename: Mark
authors.initials: M
authors.lastname: Plante
authors.forename: Gamal
authors.initials: G
authors.lastname: Eltabbakh
mesh_terms: D002292:Carcinoma, Renal Cell / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone